These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 12850329)
1. Multisite clinical trials in strict accordance with GMP standards? Poe TA Drug Discov Today; 2003 Jul; 8(13):570-3. PubMed ID: 12850329 [TBL] [Abstract][Full Text] [Related]
2. Moment of reckoning. Wadman M Nature; 2007 Apr; 446(7138):844-5. PubMed ID: 17443154 [No Abstract] [Full Text] [Related]
3. The US Food and Drug Administration's use of regular approval for cancer drugs based on single-arm studies: implications for subsequent evidence generation. DeLoughery EP; Prasad V Ann Oncol; 2018 Mar; 29(3):527-529. PubMed ID: 29346605 [No Abstract] [Full Text] [Related]
4. Who watches the watchmen? Nature; 2011 Aug; 476(7359):125. PubMed ID: 21833048 [No Abstract] [Full Text] [Related]
5. They are from the government and they really are here to help you. Woosley RL J Clin Pharmacol; 2008 Feb; 48(2):142-3. PubMed ID: 18199889 [No Abstract] [Full Text] [Related]
6. Industry looks to buck bias in emerging 'adaptive' designs. Torres C Nat Med; 2010 Jun; 16(6):619. PubMed ID: 20526301 [No Abstract] [Full Text] [Related]
7. Communicating with the FDA: the "third rail" of a new model for drug development. Stanski DR; Orloff JJ J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890 [No Abstract] [Full Text] [Related]
8. Institutional review boards: a crisis in confidence. Levine RJ Ann Intern Med; 2001 Jan; 134(2):161-3. PubMed ID: 11177321 [No Abstract] [Full Text] [Related]
9. A US Food and Drug Administration perspective on evaluating medical products for Ebola. Russek-Cohen E; Rubin D; Price D; Sun W; Cox E; Borio L Clin Trials; 2016 Feb; 13(1):105-9. PubMed ID: 26768565 [No Abstract] [Full Text] [Related]
10. FDA under pressure to relax drug rules. Ledford H Nature; 2012 Dec; 492(7427):19. PubMed ID: 23222585 [No Abstract] [Full Text] [Related]
11. Today's FDA. Slater EE N Engl J Med; 2005 Jan; 352(3):293-7. PubMed ID: 15659733 [No Abstract] [Full Text] [Related]
12. The needs of the few. Nature; 2010 Jul; 466(7303):160. PubMed ID: 20613796 [No Abstract] [Full Text] [Related]
13. Progress and deficiencies in the registration of clinical trials. Wood AJ N Engl J Med; 2009 Feb; 360(8):824-30. PubMed ID: 19228628 [No Abstract] [Full Text] [Related]
14. Surrogate Endpoints in Pediatric Studies Submitted to the US FDA. Green DJ; Sun H; Burnham J; Liu XI; van den Anker J; Temeck J; Yao L; McCune SK; Burckart GJ Clin Pharmacol Ther; 2019 Mar; 105(3):555-557. PubMed ID: 30094815 [TBL] [Abstract][Full Text] [Related]
15. News from the Society for Women's Health Research: FDA doing poor job of monitoring drugs for sex differences. Greenberger P J Womens Health Gend Based Med; 2001 Nov; 10(9):829-30. PubMed ID: 11747675 [No Abstract] [Full Text] [Related]